Primary |
Gastrointestinal Disorder |
19.4% |
Drug Use For Unknown Indication |
17.5% |
Product Used For Unknown Indication |
17.5% |
Dyspepsia |
9.7% |
Gastrooesophageal Reflux Disease |
8.7% |
Abdominal Distension |
4.9% |
Nausea |
4.9% |
Impaired Gastric Emptying |
2.9% |
Gastric Hypomotility |
1.9% |
Irritable Bowel Syndrome |
1.9% |
Post-traumatic Epilepsy |
1.9% |
Constipation |
1.0% |
Fatigue |
1.0% |
Gastric Ulcer |
1.0% |
Gastritis |
1.0% |
Headache |
1.0% |
Hypertension |
1.0% |
Oesophagitis |
1.0% |
Preoperative Care |
1.0% |
Surgery |
1.0% |
|
Tardive Dyskinesia |
28.4% |
Extrapyramidal Disorder |
11.6% |
Economic Problem |
8.4% |
Emotional Disorder |
6.3% |
Activities Of Daily Living Impaired |
5.3% |
Family Stress |
5.3% |
Dyskinesia |
4.2% |
Pain |
4.2% |
Anhedonia |
3.2% |
Deformity |
3.2% |
Tremor |
3.2% |
Anxiety |
2.1% |
Completed Suicide |
2.1% |
Dystonia |
2.1% |
Mental Disorder |
2.1% |
Partner Stress |
2.1% |
Suicidal Ideation |
2.1% |
Vomiting |
2.1% |
Adverse Reaction |
1.1% |
Arthralgia |
1.1% |
|
Secondary |
Product Used For Unknown Indication |
29.3% |
Vomiting |
12.0% |
Nausea |
11.0% |
Drug Use For Unknown Indication |
9.4% |
Breast Cancer |
4.7% |
Gastrooesophageal Reflux Disease |
3.7% |
Pain |
3.7% |
Teratoma |
3.1% |
Chemotherapy |
2.6% |
Premedication |
2.6% |
Anxiety |
2.1% |
Headache |
2.1% |
Ill-defined Disorder |
2.1% |
Prophylaxis Of Nausea And Vomiting |
2.1% |
Abdominal Distension |
1.6% |
Antiemetic Supportive Care |
1.6% |
Dyspepsia |
1.6% |
Gastric Ulcer |
1.6% |
Gastritis |
1.6% |
Grand Mal Convulsion |
1.6% |
|
Tardive Dyskinesia |
15.3% |
Extrapyramidal Disorder |
13.6% |
Anxiety |
6.8% |
Drug Hypersensitivity |
6.8% |
Drug Interaction |
6.8% |
Toxic Epidermal Necrolysis |
6.8% |
Impaired Gastric Emptying |
5.1% |
Akathisia |
3.4% |
Death |
3.4% |
Drug Ineffective |
3.4% |
Dyskinesia |
3.4% |
Gamma-glutamyltransferase Increased |
3.4% |
Parkinsonism |
3.4% |
Restless Legs Syndrome |
3.4% |
Somnolence |
3.4% |
Toxicity To Various Agents |
3.4% |
Tremor |
3.4% |
Abnormal Dreams |
1.7% |
Agranulocytosis |
1.7% |
Asthenia |
1.7% |
|
Concomitant |
Product Used For Unknown Indication |
21.6% |
Prophylaxis |
10.5% |
Drug Use For Unknown Indication |
8.3% |
Non-small Cell Lung Cancer |
8.2% |
Nausea |
7.4% |
Pain |
6.0% |
Hypertension |
5.7% |
Surgery |
5.5% |
Abdominal Pain |
4.5% |
Constipation |
2.8% |
Vomiting |
2.7% |
Anxiety |
2.6% |
Medical Diet |
2.2% |
Multiple Myeloma |
2.1% |
Gastric Cancer |
2.0% |
Acute Lymphocytic Leukaemia |
1.8% |
Back Pain |
1.6% |
Breast Cancer |
1.6% |
Dyspepsia |
1.5% |
Head And Neck Cancer |
1.5% |
|
Vomiting |
16.7% |
Thrombocytopenia |
11.3% |
Pyrexia |
6.5% |
Death |
6.0% |
Pneumonia Aspiration |
5.4% |
White Blood Cell Count Decreased |
5.4% |
Febrile Neutropenia |
4.8% |
Haemoptysis |
4.8% |
Pneumonia |
4.8% |
Septic Shock |
4.2% |
Electrolyte Imbalance |
3.6% |
Pulmonary Embolism |
3.6% |
Waist Circumference Increased |
3.6% |
Weight Decreased |
3.6% |
Abdominal Pain |
3.0% |
No Therapeutic Response |
3.0% |
Respiratory Arrest |
3.0% |
Blood Creatinine Increased |
2.4% |
Deep Vein Thrombosis |
2.4% |
Diarrhoea |
2.4% |
|
Interacting |
Anaesthesia |
50.0% |
Restless Legs Syndrome |
33.3% |
Product Used For Unknown Indication |
16.7% |
|
Drug Interaction |
60.0% |
Death |
40.0% |
|